HK Stock Market Move | Steel stocks lead the decline with crude steel production in 2025 down by 4.4% year-on-year, highlighting the persistent industry supply-demand imbalance.
Steel stocks led the decline, as of press time, China Hanking (03788) fell by 10% to HK$4.32; Angang Steel (00347) fell by 5.58% to HK$2.03; Chongqing Iron & Steel (01053) fell by 4.55% to HK$1.26; Maanshan Iron & Steel (00323) fell by 4.24% to HK$2.71.
Steel stocks lead the decline, as of the time of publication, CHINA HANKING (03788) fell by 10%, to 4.32 Hong Kong dollars; Angang Steel (00347) fell by 5.58%, to 2.03 Hong Kong dollars; CHONGQING IRON (01053) fell by 4.55%, to 1.26 Hong Kong dollars; MAANSHAN IRON (00323) fell by 4.24%, to 2.71 Hong Kong dollars.
On the news front, data released by the National Bureau of Statistics on January 19th showed that in 2025, China's crude steel output was 960 million tons, a year-on-year decrease of 4.4%, breaking through the 1 billion ton mark for the first time in six years. The market expects the national equivalent crude steel apparent consumption in 2025 to be 826 million tons (excluding billets), a year-on-year decrease of 7.1%, with a continued prominent supply-demand imbalance.
Guotai Haitong released a research report stating that with the decline in real estate, the proportion of steel demand from the real estate sector continues to decrease, and we expect the negative drag effect of real estate on steel demand to have significantly weakened. Demand from infrastructure and manufacturing sectors is expected to grow steadily. From the supply side, currently about 60% of steel enterprises are still operating at a loss, and market-driven supply clearance has begun to appear. We maintain the expectation of a contraction in the supply side, and the fundamentals of the steel industry are expected to gradually improve.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) spent 19.9599 million yuan on January 30 to repurchase 343,100 A-shares.

Guotou Securities International: Focus on investment opportunities in the coking coal sector, recommending China Risun Group (01907).
.png)
HK Stock Market Move | RUIHE DATA (03680) rose more than 12% during trading, and the company has launched a cryptocurrency asset investment plan.
Jiangsu Hengrui Pharmaceuticals (01276) spent 19.9599 million yuan on January 30 to repurchase 343,100 A-shares.

Guotou Securities International: Focus on investment opportunities in the coking coal sector, recommending China Risun Group (01907).

HK Stock Market Move | RUIHE DATA (03680) rose more than 12% during trading, and the company has launched a cryptocurrency asset investment plan.
.png)
RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


